Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOLNUPIRAVIR for Covid-19 treatment: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 3,476 adverse event reports in the FDA FAERS database where MOLNUPIRAVIR was used for Covid-19 treatment.

Most Reported Side Effects for MOLNUPIRAVIR

Side Effect Reports % Deaths Hosp.
Product use issue 706 14.8% 21 41
No adverse event 614 12.8% 0 2
Covid-19 396 8.3% 116 215
Wrong technique in product usage process 380 7.9% 9 12
Product use in unapproved indication 296 6.2% 3 14
Diarrhoea 259 5.4% 14 45
Accidental underdose 207 4.3% 0 4
Product use complaint 206 4.3% 2 4
Rash 200 4.2% 0 16
Underdose 183 3.8% 4 4
Nausea 180 3.8% 18 28
Drug ineffective 158 3.3% 19 63
Accidental overdose 145 3.0% 0 4
Vomiting 138 2.9% 6 35
Dizziness 135 2.8% 0 15

Other Indications for MOLNUPIRAVIR

Covid-19 (736) Sars-cov-2 test positive (26) Product used for unknown indication (15) Covid-19 pneumonia (13) Antiviral treatment (12) Coronavirus infection (12) Immunosuppressant drug therapy (9) Pneumonia (8) Covid-19 prophylaxis (7) Post-acute covid-19 syndrome (6)

Other Drugs Used for Covid-19 treatment

NIRMATRELVIR\RITONAVIR (44,763) CASIRIVIMAB\IMDEVIMAB (208) REMDESIVIR (156) CILGAVIMAB\TIXAGEVIMAB (146) BAMLANIVIMAB\ETESEVIMAB (85) HYDROXYCHLOROQUINE (71) SOTROVIMAB (69) BAMLANIVIMAB (66) DEXAMETHASONE (60) AZITHROMYCIN ANHYDROUS (47)

Related Pages

MOLNUPIRAVIR Full Profile All Covid-19 treatment Drugs MOLNUPIRAVIR Demographics MOLNUPIRAVIR Timeline